Biotechnology & Life Sciences
Lathrop Gage provides extensive expertise and a proven track record for clients in the Biotechnology & Life Sciences industries for all areas of intellectual property representation, including IP portfolio building, prosecution, due diligence, transactions and litigation.
Lathrop Gage represents clients in the biotechnology and life sciences sector ranging from large pharmaceutical companies to small start-ups and venture capital groups. We have nearly 70 attorneys, patent agents and technical specialists who have focused expertise in biotechnology, chemistry, high technology, patent litigation and licensing.
Lathrop Gage has a nationwide presence, with offices from Boston to Los Angeles. In keeping with the firm’s focus on the intellectual property arena, nearly all of those offices, including Boston, Boulder, Kansas City, and Los Angeles have significant IP practices. Our attorneys are supported by a team of dedicated paralegals that manages and administers the myriad deadlines and technical requirements of patent and trademark offices in the United States and abroad.
Industry Experience:
- Novel chemical entities
- Small molecule pharmaceuticals
- Prodrugs
- Implantable and external medical devices
- Biologics
- Gene therapy
- Peptide therapeutics/chemistry
- Biomarkers and diagnostics
- Antibodies, CAR-T and immunotherapies
- Oligonucleotide therapeutics including RNAi/siRNA/miRNA and anti-sense
- FDA label developments
Additional Highlights:
- Assist 3 of the top 10 global pharmaceutical companies with building out comprehensive and global patent estates in connection with multiple biologics and small molecule products in several therapeutic disease areas, including oncology, immunology, neurology and cardiology.
- Conduct freedom-to-operate (FTO) analyses, IP landscape reviews, and clearance work in connection with both early- and late-stage pharmaceutical products.
- Provide ongoing client counseling and portfolio management in connection with several marketed antibody biologics and small molecules.
- Serve as patent counsel for startup, emerging and mature biotechnology companies across the U.S. and Europe in connection with a variety of platform technologies and product pipelines in areas as diverse as antibody engineering, genome engineering, nucleic acid therapeutics, gene therapy (AAV, Adenovirus), and small molecule advancements.
News
- November 15, 2019
- April 18, 2019
- April 18, 2019
- November 28, 2018
- September 24, 2018
- August 10, 2018
- January 19, 2018
- December 12, 2012
Publications
- December 5, 2011
Press Releases
- October 24, 2019
- September 10, 2019
- September 3, 2019
- August 15, 2019
- May 14, 2019
- April 15, 2019
- November 14, 2018
- September 11, 2018
- National Law Journal Recognizes Dale Werts as a 2018 “Cryptocurrency/Blockchain/Fintech Trailblazer”September 1, 2018
- August 30, 2018
- August 15, 2018
- July 2, 2018
- May 17, 2018
- March 14, 2018
- May 8, 2017
- August 30, 2011
- January 24, 2011